Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:DOVA

Dova Pharmaceuticals (DOVA) Stock Price, News & Analysis

Dova Pharmaceuticals logo

About Dova Pharmaceuticals Stock (NASDAQ:DOVA)

Advanced Chart

Key Stats

Today's Range
$28.04
$28.04
50-Day Range
$28.04
$28.04
52-Week Range
$5.62
$28.54
Volume
35,036 shs
Average Volume
499,313 shs
Market Capitalization
$807.55 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive DOVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dova Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

DOVA Stock News Headlines

Lifelines Ahead
Crypto Is Pumping Again – Now Comes the Real Opportunity
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
Fulcrum swings back up after FDA lifts clinical hold
See More Headlines

DOVA Stock Analysis - Frequently Asked Questions

Dova Pharmaceuticals Inc (NASDAQ:DOVA) issued its quarterly earnings results on Tuesday, August, 6th. The company reported ($0.60) EPS for the quarter, missing analysts' consensus estimates of ($0.57) by $0.03. The company earned $3.52 million during the quarter, compared to the consensus estimate of $5.63 million. Dova Pharmaceuticals had a negative trailing twelve-month return on equity of 101.60% and a negative net margin of 544.09%.

Dova Pharmaceuticals (DOVA) raised $66 million in an initial public offering on Thursday, June 29th 2017. The company issued 4,100,000 shares at $15.00-$17.00 per share. J.P. Morgan, Jefferies and Leerink Partners served as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Dova Pharmaceuticals investors own include Global Blood Therapeutics (GBT), Aldeyra Therapeutics (ALDX), Allena Pharmaceuticals (ALNA), Fate Therapeutics (FATE), Fibrocell Science (FCSC), Tesaro (TSRO) and Viking Therapeutics (VKTX).

Company Calendar

Last Earnings
8/06/2019
Today
7/02/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:DOVA
Fax
N/A
Employees
115
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$72.28 million
Net Margins
-544.09%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$10.35 million
Price / Cash Flow
N/A
Book Value
$2.71 per share
Price / Book
10.35

Miscellaneous

Free Float
N/A
Market Cap
$807.55 million
Optionable
Optionable
Beta
2.74
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:DOVA) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners